FIBI Holdings: 96% Payout, 20% Loan Growth, and the Market Still Doesn't Care

FIBI Holdings: 96% Payout, 20% Loan Growth, and the Market Still Doesn't Care

The Q2 2026 numbers from FIBI Holdings are the kind of results that should make a beaten-down regional bank stock think about re-rating. Net income jumped 21.5% quarter over quarter. Credit to the public grew 20% year over year. The board approved a dividend of NIS 750 per share — a 71% jump from last year's NIS 439 — and declared a 96% payout ratio on quarterly profits. Client assets hit NIS 1.23 trillion, up 20.8% year over year.

The stock is down roughly 24% from its 52-week high and has been punished all year. The market is focused on net interest income decline, efficiency ratio pressure, and Israel's geopolitical overhang. The disconnect is that the business is growing its loan book at a 20% clip while returning virtually all profits to shareholders. A stock doing both of those things, trading near book value at roughly 10x earnings, isn't the headline it should be.

Here's what the market is missing.

1. The dividend isn't just a dividend — it's a signal.

The NIS 558 million distribution represents 96% of quarterly profit, including a portion drawn from accumulated distributable profits beyond the current quarter. A board that commits nearly all profits to shareholders while simultaneously growing the balance sheet is making a statement. This isn't a company hoarding capital for a recession. It's a bank saying its capital position is comfortable, its loan book is growing, and its cash is better spent with shareholders than sitting on the balance sheet.

The per-share payout of NIS 750, compared to NIS 439 in Q2 2025, represents a 71% increase. The dividend yield was 6.1% as of June 30. The yield has compressed since then as the stock traded lower, but the absolute commitment — NIS 750 per share per quarter — is the number that matters, not the moving-yield artifact of price.

2. Loan growth of 20% doesn't happen in a failing economy.

Credit to the public grew to NIS 164.2 billion, up 20.1% year over year and 5.9% from Q1. That's not maintenance lending. That's expansion in an environment where most banks would be tightening. Deposits grew 11.7% year over year to NIS 251.4 billion, so the funding side is supporting the growth. Fee and commission income climbed 9.1% in the first half to NIS 937 million, showing the capital markets and advisory side is pulling its weight.

The market has been pricing a war-affected, recession-bound Israel. The loan book growth says otherwise. When a bank is extending credit at 20% growth while its non-performing loan ratio improves to 0.40% from 0.46% at year-end 2025, that's not a bank bracing for losses. That's a bank with a high-quality portfolio that keeps expanding.

3. The margin story is real, but it's macro, not structural.

Net interest income fell to NIS 1,194 million in Q2 from NIS 1,290 million a year earlier. The efficiency ratio widened to 46.1% from 43.1% in the prior-year quarter. These are not cosmetic wiggles. Management attributed the revenue decline to macroeconomic shifts in CPI, interest rates, and exchange rates, plus commission expenses from expanded capital markets operations driving the efficiency ratio higher.

The question is whether this is temporary or structural. Interest rate normalization compresses net interest margins across the sector — that's an industry-wide headwind, not a FIBI-specific problem. The commission expense increase is a choice: the bank is investing in higher-fee capital markets activity. Fee income is already growing 9% in the first half. This looks like growing pains from a deliberate pivot, not a business model breaking down.

Return on equity of 16.0% in Q2 — 17.8% excluding a special tax levy imposed in 2026 — is still solid for a bank trading at 10x earnings. The tax levy is a one-time drag, not a recurring cost.

4. Asset quality is a quiet strength.

The NPL ratio improved to 0.40%, down from 0.46% at year-end 2025. Exposure to problem credit risk declined 25% in the first half. The provision ratio for credit losses fell to 1.08% from 1.33% a year ago. In a geopolitical environment with an active conflict, these numbers are quietly remarkable. They don't make headlines, but they tell you the credit book is clean and management is confident enough to reduce reserves.

5. The valuation math doesn't match the bear narrative.

FIBI trades at roughly 10x trailing earnings, right in line with the sector average. The stock is down roughly 20% year to date and about 24% below its 52-week high. Against a backdrop of 6.1% dividend yield, 20% loan growth, improving asset quality, and a 96% payout ratio, the valuation isn't pricing in any of that. It's pricing in macro anxiety.

Peer Bank Leumi just posted record Q2 profits with an efficiency ratio of 24.7% — a number that makes FIBI's 46.1% look worse by comparison. But Leumi also trades at roughly 10.8x earnings, and the sector-wide average is 10.5x. FIBI isn't trading at a premium, but it isn't at a meaningful discount either. The question isn't whether FIBI is the cheapest Israeli bank. The question is whether a 6% dividend, 20% loan growth, and improving credit quality justify the price the market has assigned it.

What breaks the setup

A sharp Israeli recession that forces credit losses higher would change the calculus quickly. The NPL ratio is low, but that means there's room for it to deteriorate before it becomes a headline problem. If net interest income continues to compress beyond a single cycle of rate normalization, the 96% payout ratio becomes unsustainable and the dividend signal flips from strength to desperation. That's the primary risk — a credit event or a margin collapse that the current loan growth numbers haven't priced in yet.

On the flip side, the catalyst for re-rating is already embedded in the numbers. If the dividend holds at the NIS 750 per-share level through Q3 and loan growth stays above 15%, the income and growth story becomes hard to ignore. At roughly 10x earnings with a 6% yield, FIBI is trading at a multiple that assumes the best is behind it. The loan book and the board's capital allocation decisions say something different.